Fujifilm's factory in Denmark generates USD 430m revenue

Fujifilm Diosynth Biotechnologies, a Japan-based company that produces drugs for other firms, has released its first annual accounting report since it started operating in Denmark. This comes two years after the company bought a medicine factory in the country.
Lars Petersen, CEO of Fujifilm Diosynth Biotechnologies in Denmark | Photo: Fujifilm Diosynth Biotechnologies
Lars Petersen, CEO of Fujifilm Diosynth Biotechnologies in Denmark | Photo: Fujifilm Diosynth Biotechnologies
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY CATHERINE BRETT

Two years after Fujifilm Diosynth Biotechnologies (FDB) spent DKK 6bn (USD 960m) on a medicine factory in Northern Zealand, Denmark, the contract producer has released its first annual accounting report for its Danish operations.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading